Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Pediatric Perindopril in Hypertensive Children
NCT00202592Phase 2Completed
- Sponsor
- Servier
- Start
- Nov 2003
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perindopril in hypertension (HTN), sponsored by Servier. Primary endpoint: Clinical safety assessed from the patient's (parents) complaints and clinical follow-up at 24 months. Started Nov 2003; status: completed.
02
Drugs
perindopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00202592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202592.